Loading provider…
Loading provider…
Gynecologic Oncology Physician in Seattle, WA
NPI: 1467538264Primary Practice Location
UNIVERSITY OF WASHINGTON MEDICAL CTR
1959 Ne Pacific St, Seattle, WA
Primary Employer
University of Washington Physicians
uwmedicine.org
HQ Phone
Get Barbara's Phone Numberphone_androidMobile
Get Barbara's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardWA State Medical License
WA State Medical License
1992 - 2026

American Board of Obstetrics and Gynecology
Obstetrics & Gynecology

American Board of Obstetrics and Gynecology
Gynecologic Oncology
Perelman School of Medicine - Philadelphia
med.upenn.edu
Medical School
Until 1986
Mass General Brigham/Massachusetts General Hospital
Fellowship • Gynecologic Oncology
1990 - 1993
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital
Residency • Obstetrics and Gynecology
1987 - 1990
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 43 | 84 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 25 | 34 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 14 | 14 |
The Cost of Initial Care for Medicare Patients With Advanced Ovarian Cancer
Authors: Renata Urban
Journal: J Natl Compr Canc Netw
Authors: Joshua Kesterson, Shitanshu Uppal, Bhavana Pothuri, Jubilee Brown, Jamie Bakkum-Gamez, Pamela Soliman, Mario Leitao, Stephanie Wethington, Stephanie Blank, Amer Karam, Abdulrahman Sinno, Jason Wright, Warner Huh, Martin Martino, Sean Dowdy
Journal: Gynecol Oncol
Publication Date: 2020-06-06
Telomerase activation in cervical cancer
Authors: Benjamin Greer
Journal: Am J Pathol
Lead Sponsor: MEI Pharma, Inc.
Collaborators: SCRI Development Innovations, LLC
Intervention / Treatment: DRUG: Topotecan, DRUG: ME-344
Lead Sponsor: Fred Hutchinson Cancer Center
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: gemcitabine hydrochloride, DRUG: topotecan hydrochloride